Global Cord Blood (NYSE:CO) Shares Pass Above 200 Day Moving Average - Here's What Happened

Key Points

• Global Cord Blood shares surpassed their 200-day moving average of $0.98, reaching a trading high of $1.35.
• Wall Street Zen has initiated coverage on Global Cord Blood, issuing a "strong-buy" rating on the stock.
• The company has seen a significant stock price increase of 90.1% recently, with a market capitalization of $164.09 million.

Global Cord Blood Co. (NYSE:CO - Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.98 and traded as high as $1.35. Global Cord Blood shares last traded at $1.35, with a volume of 0 shares trading hands.

Analyst Ratings Changes

Separately, Wall Street Zen assumed coverage on Global Cord Blood in a research note on Saturday, May 17th. They issued a "strong-buy" rating on the stock.

Global Cord Blood Stock Up 90.1%

The firm's 50-day simple moving average is $1.00 and its 200-day simple moving average is $0.98. The firm has a market capitalization of $164.09 million, a PE ratio of 2.11 and a beta of 0.16.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.